Filed 2.3y ago· Mar 2, 2024
19 days to disclose
Earl Blumenauer
—HouseOregon-03
↑bought
Pfizer
PFE
$1K-$15K
−44.9% vs S&P 500
Trade dateFeb 12, 2024
Pfizer, Inc.
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–10 of 10
Filed 3.7y ago· Oct 5, 2022
9 days to discloseEarl Blumenauer
—HouseOregon-03
↑bought
Amgen
AMGN
$1K-$15K
−44.1% vs S&P 500
Trade dateSep 26, 2022
Filed 3.7y ago· Oct 5, 2022
20 days to discloseEarl Blumenauer
—HouseOregon-03
↓sold
Merck
MRK
$15K-$50K
+16.2% vs S&P 500
Trade dateSep 15, 2022
Filed 3.9y ago· Jul 6, 2022
40 days to discloseEarl Blumenauer
—HouseOregon-03
↑bought
Sanofi
SNY
$15K-$50K
−87.1% vs S&P 500
Trade dateMay 27, 2022
Filed 4.2y ago· Apr 1, 2022
18 days to discloseEarl Blumenauer
—HouseOregon-03
↓sold
Pfizer
PFE
$1K-$15K
+14.4% vs S&P 500
Trade dateMar 14, 2022
Filed 4.2y ago· Apr 1, 2022
18 days to discloseEarl Blumenauer
—HouseOregon-03
↓sold
Amgen
AMGN
$1K-$15K
+14.4% vs S&P 500
Trade dateMar 14, 2022
Filed 4.2y ago· Apr 1, 2022
36 days to discloseEarl Blumenauer
—HouseOregon-03
↑bought
Pfizer
PFE
$1K-$15K
−59.2% vs S&P 500
Trade dateFeb 24, 2022
Filed 4.2y ago· Apr 1, 2022
36 days to discloseEarl Blumenauer
—HouseOregon-03
↑bought
Amgen
AMGN
$1K-$15K
+25.5% vs S&P 500
Trade dateFeb 24, 2022
Filed 4.2y ago· Mar 7, 2022
18 days to discloseEarl Blumenauer
—HouseOregon-03
↓sold
Amgen
AMGN
$1K-$15K
Trade dateFeb 17, 2022
Filed 5.0y ago· Jun 9, 2021
12 days to discloseEarl Blumenauer
—HouseOregon-03
↓sold
Pfizer
PFE
$1K-$15K
+100.3% vs S&P 500
Trade dateMay 28, 2021
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Mar 2, 2024 2.3y ago | Earl Blumenauer —HouseOregon-03 | ↑bought | Pfizer PFE Pfizer, Inc. | Feb 12, 2024 19 days to disclose | Bad buy·−$191-2.4% −44.9% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 5, 2022 3.7y ago | Earl Blumenauer —HouseOregon-03 | ↑bought | Amgen AMGN | Sep 26, 2022 9 days to disclose | Good buy·+$4.1K+51.9% −44.1% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 5, 2022 3.7y ago | Earl Blumenauer —HouseOregon-03 | ↓sold | Merck MRK | Sep 15, 2022 20 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jul 6, 2022 3.9y ago | Earl Blumenauer —HouseOregon-03 | ↑bought | Sanofi SNY | May 27, 2022 40 days to disclose | Bad buy·−$4.9K-15.2% −87.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 1, 2022 4.2y ago | Earl Blumenauer —HouseOregon-03 | ↓sold | Pfizer PFE | Mar 14, 2022 18 days to disclose | Flat·+0.0% +14.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 1, 2022 4.2y ago | Earl Blumenauer —HouseOregon-03 | ↓sold | Amgen AMGN | Mar 14, 2022 18 days to disclose | Flat·+0.0% +14.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 1, 2022 4.2y ago | Earl Blumenauer —HouseOregon-03 | ↑bought | Pfizer PFE | Feb 24, 2022 36 days to disclose | Bad buy·−$3.4K-42.3% −59.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 1, 2022 4.2y ago | Earl Blumenauer —HouseOregon-03 | ↑bought | Amgen AMGN | Feb 24, 2022 36 days to disclose | Good buy·+$3.4K+42.4% +25.5% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 7, 2022 4.2y ago | Earl Blumenauer —HouseOregon-03 | ↓sold | Amgen AMGN | Feb 17, 2022 18 days to disclose | price pending | $1K-$15K midpoint $8K |
Jun 9, 2021 5.0y ago | Earl Blumenauer —HouseOregon-03 | ↓sold | Pfizer PFE | May 28, 2021 12 days to disclose | Smart sell·+$2.4K+30.3% +100.3% vs S&P 500 | $1K-$15K midpoint $8K |